Natera to Participate in Upcoming Investor Conferences - Feb 11, 2021

Natera将参加即将举行的投资者会议-2021年2月11日

2021-02-12 15:51:10 BioSpace

本文共849个字,阅读需3分钟

Natera, Inc. , a pioneer and global leader in cell-free DNA testing, today announced that Alexey Aleshin, MD, Natera's Senior Medical Director of Oncology, will participate in a panel discussion at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference. Additionally, Steve Chapman, CEO, and Mike Brophy, CFO, will participate in a fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference. Details are as follows: BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference Date: Thursday, February 18, 2021 Time: 10:00 a.m. PT (1:00 p.m. ET) 10th Annual SVB Leerink Global Healthcare Conference Date: Friday, February 26, 2021 Time: 11:20 a.m. PT (2:20 p.m. ET) Access to the live webcasts will be available at investor.natera.com. About Natera Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn. Contacts Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350 Media: Paul Greenland, VP of Corporate Marketing, Natera, Inc., pr@natera.com multimedia:http://www.prnewswire.com/news-releases/natera-to-participate-in-upcoming-investor-conferences-301226652.html
Natera公司是无细胞DNA检测领域的先驱和全球领先者,今天宣布,Natera肿瘤学高级医学总监Alexey Aleshin医学博士将参加BTIG虚拟医疗技术、数字健康、生命科学和诊断工具会议的小组讨论。此外,首席执行官Steve Chapman和首席财务官Mike Brophy将参加第十届SVB Leerink全球医疗保健年会的炉边谈话。 详情如下: BTIG虚拟医疗技术、数字健康、生命科学和诊断工具会议 日期: 2021年2月18日星期四 时间: 美国东部时间上午10:00(东部时间下午1:00) 第十届SVB Leerink全球医疗保健年会 日期: 2021年2月26日星期五 时间: 印度时间上午11时20分(东部时间下午2时20分) 可在investor.natera.com访问现场网播。 关于Natera Natera是通过简单抽血进行无细胞DNA检测的先驱和全球领先者。该公司的使命是改变世界范围内的疾病管理,重点关注妇女健康、肿瘤学和器官健康。Natera在加利福尼亚州圣卡洛斯和得克萨斯州奥斯汀经营着通过ISO 13485认证和CAP认证的实验室,这些实验室是根据临床实验室改进修正案(CLIA)认证的。它提供专有的基因检测服务,通过其基于云的软件平台为产科医生、移植医生、肿瘤医生和癌症研究人员(包括生物制药公司)和基因实验室提供信息。欲了解更多信息,请访问natera.com。在LinkedIn上关注Natera。 联系人 投资者关系:Mike Brophy,CFO,Natera,Inc.,510-826-2350 媒体:Paul Greenland,Natera,Inc.公司营销副总裁,pr@Natera.com 多媒体:http://www.prnewswire.com/news-releases/natera-to-participate-in-upcoming-investor-conferences-301226652.html

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文